Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study
- DOI
- 10.1161/circheartfailure.123.011381
- Published
- 2025-03-11
- Container
- Circulation. Heart failure
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1161/circheartfailure.123.011381,
title = {Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study},
author = {Sanjiv J Shah and Diana Bonderman and Barry A Borlaug and John G.F. Cleland and Gabriela Lack and Wentao Lu and Adriaan A Voors and Faiez Zannad and Mark T Gladwin},
year = {2025},
journal = {Circulation. Heart failure},
doi = {10.1161/circheartfailure.123.011381},
url = {https://doi.org/10.1161/circheartfailure.123.011381}
}RIS
TY - JOUR TI - Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study AU - Sanjiv J Shah AU - Diana Bonderman AU - Barry A Borlaug AU - John G.F. Cleland AU - Gabriela Lack AU - Wentao Lu AU - Adriaan A Voors AU - Faiez Zannad AU - Mark T Gladwin PY - 2025 JO - Circulation. Heart failure DO - 10.1161/circheartfailure.123.011381 UR - https://doi.org/10.1161/circheartfailure.123.011381 ER -
APA
Shah, S. J., Bonderman, D., Borlaug, B. A., Cleland, J. G., Lack, G., Lu, W., Voors, A. A., Zannad, F., & Gladwin, M. T. (2025). Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study. Circulation. Heart failure. https://doi.org/10.1161/circheartfailure.123.011381
Source records
- hal · retrieved 2026-09-27T11:48:04.115Z